Literature DB >> 12654960

Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy.

C Juhász1, D C Chugani, O Muzik, A Shah, E Asano, T J Mangner, P K Chakraborty, S Sood, H T Chugani.   

Abstract

BACKGROUND: In children with tuberous sclerosis, the PET tracer alpha[11C]methyl-L-tryptophan (AMT) has been shown to be selectively taken up by epileptogenic tubers, thus allowing differentiation from nonepileptogenic tubers in the interictal state.
OBJECTIVE: To determine whether cortical areas showing increased AMT uptake in children without tuberous sclerosis complex with intractable neocortical epilepsy indicate the epileptogenic zone, and to assess the relative contributions of AMT and 2-deoxy-2[18F]fluoro-D-glucose (FDG) PET abnormalities to the localization of epileptogenic cortical regions.
METHODS: Areas of increased AMT and decreased FDG uptake were marked objectively as regions with abnormal asymmetry using an in-house written software in 27 children who underwent comprehensive evaluation for resective epilepsy surgery. The marked PET abnormalities were compared to the locations of scalp and subdural EEG epileptiform abnormalities, as well as histology and surgical outcome.
RESULTS: Focal cortical increases of AMT uptake were found in 15 patients. The lobar sensitivity (39.0%) of AMT PET for seizure onset was lower, but its specificity (100%) was higher (p < 0.0001) than that of hypometabolism on FDG PET (sensitivity 73.2%, specificity 62.7%). AMT PET abnormalities were smaller than corresponding FDG PET hypometabolic regions (p = 0.002), and increased AMT uptake occurred in two patients with nonlocalizing FDG PET. Histologically verified cortical developmental malformations were associated with increased AMT uptake (p = 0.044). Subdural electrodes adjacent to the area of increased AMT uptake were most often involved in seizure onset.
CONCLUSIONS: Focal increase of cortical AMT uptake in children is less sensitive but more specific for the lobe of seizure onset than corresponding FDG PET hypometabolism, and it is often associated with epileptogenic cortical developmental malformations. AMT PET can assist placement of subdural electrodes even when MRI and FDG PET fail to provide adequate localizing information. Cortical areas adjacent to increased AMT uptake should be carefully addressed by intracranial EEG because these regions often show a high degree of epileptogenicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654960     DOI: 10.1212/01.wnl.0000049468.05050.f2

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Objective detection of epileptic foci by 18F-FDG PET in children undergoing epilepsy surgery.

Authors:  Ajay Kumar; Csaba Juhász; Eishi Asano; Sandeep Sood; Otto Muzik; Harry T Chugani
Journal:  J Nucl Med       Date:  2010-11-15       Impact factor: 10.057

Review 2.  α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.

Authors:  Ajay Kumar; Eishi Asano; Harry T Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 3.  α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions.

Authors:  Diane C Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 4.  Neuroimaging of epilepsy: therapeutic implications.

Authors:  Ruben I Kuzniecky
Journal:  NeuroRx       Date:  2005-04

5.  Imaging of serotonin mechanisms in epilepsy.

Authors:  Harry T Chugani; Diane C Chugani
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

Review 6.  Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy.

Authors:  Sandeep Sood; Harry T Chugani
Journal:  Childs Nerv Syst       Date:  2006-06-24       Impact factor: 1.475

7.  PET imaging in pediatric neuroradiology: current and future applications.

Authors:  Sunhee Kim; Noriko Salamon; Hollie A Jackson; Stefan Blüml; Ashok Panigrahy
Journal:  Pediatr Radiol       Date:  2009-11-24

8.  Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.

Authors:  Csaba Juhász; Otto Muzik; Diane C Chugani; Harry T Chugani; Sandeep Sood; Pulak K Chakraborty; Geoffrey R Barger; Sandeep Mittal
Journal:  J Neurooncol       Date:  2010-07-30       Impact factor: 4.130

9.  PET radiopharmaceuticals for probing enzymes in the brain.

Authors:  Jason P Holland; Paul Cumming; Neil Vasdev
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

10.  Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy.

Authors:  Harry T Chugani; Ajay Kumar; William Kupsky; Eishi Asano; Sandeep Sood; Csaba Juhász
Journal:  Epilepsia       Date:  2011-05-13       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.